These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7868851)
21. [Clinical effectiveness of zotepine in treatment of negative schizophrenic symptoms. Results of an open and a double-blind controlled trial]. Müller-Spahn F; Dieterle D; Ackenheil M Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():30-5. PubMed ID: 1683337 [TBL] [Abstract][Full Text] [Related]
22. Results of an open phase II study with zotepine--a new neuroleptic compound. Fleischhacker WW; Unterweger B; Barnas C; Stuppäck C; Hinterhuber H Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):64-6. PubMed ID: 2883686 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of zotepine for the treatment of Taiwanese schizophrenic patients: a double-blind comparison with haloperidol. Hwang TJ; Lin SK; Lin HN J Formos Med Assoc; 2001 Dec; 100(12):811-6. PubMed ID: 11802520 [TBL] [Abstract][Full Text] [Related]
24. A placebo-controlled comparison of zotepine versus chlorpromazine in patients with acute exacerbation of schizophrenia. Cooper SJ; Tweed J; Raniwalla J; Butler A; Welch C Acta Psychiatr Scand; 2000 Mar; 101(3):218-25. PubMed ID: 10721870 [TBL] [Abstract][Full Text] [Related]
25. Clinical and EEG studies of zotepine, a thiepine neuroleptic, on schizophrenic patients. Higashi Y; Momotani Y; Suzuki E; Kaku T Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):8-11. PubMed ID: 2883687 [TBL] [Abstract][Full Text] [Related]
26. Clinical and neuroendocrine effects of zotepine--a new neuroleptic drug. von Bardeleben U; Benkert O; Holsboer F Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):28-34. PubMed ID: 2883678 [TBL] [Abstract][Full Text] [Related]
27. Serum prolactin, psychopathology, and ventricular size in chronic schizophrenia. Luchins DJ; Robertson AG; Meltzer HY Psychiatry Res; 1984 Jun; 12(2):149-53. PubMed ID: 6147869 [TBL] [Abstract][Full Text] [Related]
28. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Meltzer HY; Busch DA; Fang VS Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660 [TBL] [Abstract][Full Text] [Related]
29. Comparison of efficacy of zotepine and thiothixene in schizophrenia in a double-blind study. Sarai K; Okada M Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):38-46. PubMed ID: 2883680 [TBL] [Abstract][Full Text] [Related]
30. Risperidone-induced increase in serum prolactin is correlated with positive symptom improvement in chronic schizophrenia. Zhang XY; Zhou DF; Yuan CL; Zhang PY; Wu GY; Shen YC Psychiatry Res; 2002 Apr; 109(3):297-302. PubMed ID: 11959366 [TBL] [Abstract][Full Text] [Related]
31. [Double-blind comparison of 3 x 75 mg zotepine und 3 x 4 mg haloperidol in acute schizophrenic patients]. Klieser E; Lehmann E; Tegeler J Fortschr Neurol Psychiatr; 1991 Sep; 59 Suppl 1():14-7. PubMed ID: 1683333 [TBL] [Abstract][Full Text] [Related]
32. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309 [TBL] [Abstract][Full Text] [Related]
33. Biperiden and piroheptine do not affect the serum level of zotepine, a new antipsychotic drug. Otani K; Hirano T; Kondo T; Kaneko S; Fukushima Y; Noda K; Tashiro Y Br J Psychiatry; 1990 Jul; 157():128-30. PubMed ID: 1975759 [TBL] [Abstract][Full Text] [Related]
34. Serum prolactin as a correlate of clinical response to haloperidol. Van Putten T; Marder SR; Mintz J J Clin Psychopharmacol; 1991 Dec; 11(6):357-61. PubMed ID: 1770154 [TBL] [Abstract][Full Text] [Related]
35. Serum prolactin levels and the acute-phase efficacy in drug-naïve schizophrenia treated with ziprasidone and olanzapine (translated version). Wu XL; Wang JH; Hu SH; Tao J East Asian Arch Psychiatry; 2012 Mar; 22(1):7-11. PubMed ID: 22447799 [TBL] [Abstract][Full Text] [Related]
36. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response. Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566 [TBL] [Abstract][Full Text] [Related]
37. Serum neuroleptic levels, prolactin levels, and relapse: a two-year study of schizophrenic outpatients. Faraone SV; Brown WA; Laughren TP J Clin Psychiatry; 1987 Apr; 48(4):151-4. PubMed ID: 2881923 [TBL] [Abstract][Full Text] [Related]
38. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia. Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206 [TBL] [Abstract][Full Text] [Related]
39. Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin. Kondo T; Ishida M; Tokinaga N; Mihara K; Yasui-Furukori N; Ono S; Kaneko S Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):287-91. PubMed ID: 11817505 [TBL] [Abstract][Full Text] [Related]
40. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays. Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]